Über Peptidyl‐Prolyl‐cis/trans‐Isomerasen und ihre Effektoren
暂无分享,去创建一个
[1] N. Burres,et al. Preliminary characterization of a cloned neutral isoelectric form of the human peptidyl prolyl isomerase cyclophilin. , 1991, The Journal of biological chemistry.
[2] N. Sigal,et al. Observations on the mechanism of action of FK-506. A pharmacologic probe of lymphocyte signal transduction. , 1990, Biochemical pharmacology.
[3] R. M. Justice,et al. The detection of proline isomerase activity in FK506-binding protein by two-dimensional 1H NMR exchange spectroscopy. , 1990, Biochemical and biophysical research communications.
[4] G. P. Livi,et al. Cloning and sequence analysis of a rapamycin-binding protein-encoding gene (RBP1) from Candida albicans. , 1992, Gene.
[5] J. Brandts,et al. Evidence suggesting that some proteolytic enzymes may cleave only the trans form of the peptide bond. , 1979, Biochemistry.
[6] A. Superti-Furga,et al. Cyclosporin A slows collagen triple-helix formation in vivo: indirect evidence for a physiologic role of peptidyl-prolyl cis-trans-isomerase. , 1991, The Journal of biological chemistry.
[7] Jun O. Liu,et al. Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. , 1992, Biochemistry.
[8] T. Kiefhaber,et al. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins , 1989, Nature.
[9] Andrzej Galat,et al. Molecular cloning and overexpression of the human FK506-binding protein FKBP , 1990, Nature.
[10] M. Lowdell,et al. Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[11] G. Sanyal,et al. Stabilization of the FK506 binding protein by ligand binding. , 1991, Biochemical and Biophysical Research Communications - BBRC.
[12] A. Sarris,et al. IMMUNOFLUORESCENT LOCALIZATION AND IMMUNOCHEMICAL DETERMINATION OF CYCLOPHILIN‐A WITH SPECIFIC RABBIT ANTISERA , 1992, Transplantation.
[13] William Arbuthnot Sir Lane,et al. Isolation of the cyclosporin-sensitive T cell transcription factor NFATp. , 1993, Science.
[14] M. Harding,et al. Cyclophilin: distribution and variant properties in normal and neoplastic tissues. , 1986, Journal of immunology.
[15] D. Bergsma,et al. A single Trp121 to Ala121 mutation in human cyclophilin alters cyclosporin A affinity and peptidyl-prolyl isomerase activity. , 1991, Biochemical and biophysical research communications.
[16] G. Fischer,et al. Conformational specificity of chymotrypsin toward proline-containing substrates. , 1984, Biochimica et biophysica acta.
[17] P. Bernstein,et al. Biochemical characterization of the retinoid isomerase system of the eye. , 1987, The Journal of biological chemistry.
[18] B. Bierer,et al. Immunosuppressants FK506 and rapamycin function as reversal agents of the multidrug resistance phenotype. , 1992, Blood.
[19] Stuart L. Schreiber,et al. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes , 1991, Cell.
[20] R. Handschumacher,et al. Isolation and partial characterization of membrane-associated cyclophilin and a related 22-kDa glycoprotein. , 1992, European journal of biochemistry.
[21] C. Lyttle,et al. Leukocyte chemotactic activity of cyclophilin. , 1992, The Journal of biological chemistry.
[22] J. Liu,et al. Crystal structure of recombinant human T-cell cyclophilin A at 2.5 A resolution. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[23] R. Wolfenden,et al. Cis/trans isomerization at proline: Desolvation and its consequences for protein folding , 1992 .
[24] B. Ryffel,et al. Identification of the multidrug resistance-related P-glycoprotein as a cyclosporine binding protein. , 1989, Molecular pharmacology.
[25] J. Heitman,et al. FK 506-binding protein proline rotamase is a target for the immunosuppressive agent FK 506 in Saccharomyces cerevisiae. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[26] B. Ryffel,et al. CYCLOSPORINE—RELATIONSHIP OF SIDE EFFECTS TO MODE OF ACTION , 1988, Transplantation.
[27] F. Schmid,et al. Protein-disulphide isomerase and prolyl isomerase act differently and independently as catalysts of protein folding , 1988, Nature.
[28] F. Mitelman,et al. t(3;6;14)(p21;p21;q24) as the sole clonal chromosome abnormality in a hamartoma of the lung. , 1992, Cancer genetics and cytogenetics.
[29] D. Bergsma,et al. A Candida albicans homolog of a human cyclophilin gene encodes a peptidyl-prolyl cis-trans isomerase. , 1990, Gene.
[30] R. Rudolph,et al. Prolyl isomerases catalyze antibody folding in vitro , 1993, Protein science : a publication of the Protein Society.
[31] E. Baulieu,et al. P59, an hsp 90-binding protein. Cloning and sequencing of its cDNA and preparation of a peptide-directed polyclonal antibody. , 1992, The Journal of biological chemistry.
[32] M. Levitt. Effect of proline residues on protein folding. , 1981, Journal of molecular biology.
[33] J. Heitman,et al. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast , 1991, Science.
[34] S. Burakoff,et al. Probing immunosuppressant action with a nonnatural immunophilin ligand , 1990, Science.
[35] W. Pak,et al. Drosophila ninaA gene encodes an eye-specific cyclophilin (cyclosporine A binding protein). , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[36] C. Deber,et al. Hypothesis about the function of membrane-buried proline residues in transport proteins. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[37] Evidence for the existence of three or more slow phases in the refolding of ribonuclease A and some characteristics of the phases. , 1987, Biochemistry.
[38] C. Horváth,et al. Effect of molecular structure and conformational change of proline-containing dipeptides in reversed-phase chromatography , 1982 .
[39] S. Sehgal,et al. FK506 and rapamycin: novel pharmacological probes of the immune response. , 1991, Trends in pharmacological sciences.
[40] J. Garel,et al. Optical measurement of a solvent-induced isomerization in a proline-containing hexapeptide. , 1979, Biochemical and biophysical research communications.
[41] FKB1 encodes a nonessential FK 506-binding protein in Saccharomyces cerevisiae and contains regions suggesting homology to the cyclophilins. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[42] A. Fersht,et al. Folding of chymotrypsin inhibitor 2. 2. Influence of proline isomerization on the folding kinetics and thermodynamic characterization of the transition state of folding. , 1991, Biochemistry.
[43] H. Ke,et al. Similarities and differences between human cyclophilin A and other beta-barrel structures. Structural refinement at 1.63 A resolution. , 1992, Journal of molecular biology.
[44] U. Hahn,et al. Folding of ribonuclease T1. 1. Existence of multiple unfolded states created by proline isomerization. , 1990, Biochemistry.
[45] D. Bergsma,et al. A second cyclophilin-related gene in Saccharomyces cerevisiae. , 1990, Nucleic acids research.
[46] J. Liu,et al. Human and Escherichia coli cyclophilins: sensitivity to inhibition by the immunosuppressant cyclosporin A correlates with a specific tryptophan residue. , 1991, Biochemistry.
[47] J. Sutcliffe,et al. p1B15: a cDNA clone of the rat mRNA encoding cyclophilin. , 1988, DNA.
[48] G. Fischer,et al. Kinetic β‐deuterium isotope effects suggest a covalent mechanism for the protein folding enzyme peptidylprolyl cis/trans‐isomerase , 1989, FEBS letters.
[49] T. Soderling,et al. NF-ATp, a T lymphocyte DNA-binding protein that is a target for calcineurin and immunosuppressive drugs. , 1993, The Journal of biological chemistry.
[50] T. Ocain,et al. A nonimmunosuppressive triene-modified rapamycin analog is a potent inhibitor of peptidyl prolyl cis-trans isomerase. , 1993, Biochemical and biophysical research communications.
[51] G. Fritzsch,et al. Cyclosporin binding to a protein component of the renal Na(+)-D-glucose cotransporter. , 1990, The Journal of biological chemistry.
[52] S. Koda,et al. Tautomeric phenomenon of a novel potent immunosuppressant (FK506) in solution. I. Isolation and structure determination of tautomeric compounds. , 1993, The Journal of antibiotics.
[53] M. Mclaughlin,et al. The yeast cyclophilin multigene family: purification, cloning and characterization of a new isoform. , 1992, Gene.
[54] T. Seng,et al. Cyclophilin-40, a protein with homology to the P59 component of the steroid receptor complex. Cloning of the cDNA and further characterization. , 1993, The Journal of biological chemistry.
[55] C. Deber,et al. Proline residues in transmembrane helices: structural or dynamic role? , 1991, Biochemistry.
[56] A. Pahl,et al. FK-506-binding proteins from streptomycetes producing immunosuppressive macrolactones of the FK-506 type , 1992, Journal of bacteriology.
[57] Y. Tanigawara,et al. Human P-glycoprotein transports cyclosporin A and FK506. , 1993, The Journal of biological chemistry.
[58] R. Bundick,et al. FK506 AS AN AGONIST TO INDUCE INHIBITION OF INTERLEUKIN 2 PRODUCTION , 1992, Transplantation.
[59] G. Crabtree,et al. The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes. , 1990, The EMBO journal.
[60] Jean Kanitakis,et al. [Non-immunologic effects of cyclosporins]. , 1991, Pathologie-biologie.
[61] D. Speicher,et al. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. , 1984, Science.
[62] C. Walsh,et al. Hsp90 chaperonins possess ATPase activity and bind heat shock transcription factors and peptidyl prolyl isomerases. , 1993, The Journal of biological chemistry.
[63] C. Walsh,et al. Overexpression, purification, and characterization of yeast cyclophilins A and B , 1992, Protein science : a publication of the Protein Society.
[64] N. Cianciotto,et al. Nucleotide sequence analysis of the Legionella micdadei mip gene, encoding a 30-kilodalton analog of the Legionella pneumophila Mip protein , 1991, Infection and immunity.
[65] Horst Kessler,et al. Reinvestigation of the Conformation of Cyclosporin A in Chloroform , 1990 .
[66] H. Hasumi,et al. Purification and properties of multiple molecular forms of yeast peptidyl prolyl cis-trans isomerase. , 1993, Biochimica et biophysica acta.
[67] K. W. Hasel,et al. Nucleotide sequence of a cDNA coding for mouse cyclophilin , 1990, Nucleic Acids Res..
[68] G. Fischer,et al. Zur theorie der α-ketosäuren : Beziehungen zwischen struktur und UV-Spektren von α-ketosäuren und verwandten α-dicarbonylverbindungen☆ , 1971 .
[69] N. Takahashi,et al. Two distinct forms of peptidylprolyl-cis-trans-isomerase are expressed separately in periplasmic and cytoplasmic compartments of Escherichia coli cells. , 1991, Biochemistry.
[70] C. Walsh,et al. Cyclosporin-mediated inhibition of bovine calcineurin by cyclophilins A and B. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[71] K. Dietmeier,et al. Nucleotide sequence of a full-length cDNA coding for cyclophilin (peptidyl-prolyl cis-trans isomerase) of Saccharomyces cerevisiae. , 1990, Nucleic acids research.
[72] J. Segall,et al. cDNA sequence of cyclophilin from Dictyostelium discoideum. , 1991, Developmental genetics.
[73] Nolan H. Sigal,et al. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin , 1989, Nature.
[74] H. Lodish,et al. Cyclosporin A inhibits an initial step in folding of transferrin within the endoplasmic reticulum. , 1991, The Journal of biological chemistry.
[75] G. Crabtree,et al. Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation. , 1989, Science.
[76] C. Zuker,et al. Genetic dissection of cyclophilin function. Saturation mutagenesis of the Drosophila cyclophilin homolog ninaA. , 1992, The Journal of biological chemistry.
[77] M. Mclaughlin,et al. The tyrosine89 residue of yeast FKBP12 is required for rapamycin binding. , 1993, Gene.
[78] M. Hjelm,et al. Cyclosporin A and its Metabolites, Distribution in Blood and Tissues , 1991, The Journal of international medical research.
[79] M. Godbout,et al. An endoplasmic reticulum-specific cyclophilin , 1991, Molecular and cellular biology.
[80] G. Crabtree,et al. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase , 1992, Nature.
[81] H. Bächinger. The influence of peptidyl-prolyl cis-trans isomerase on the in vitro folding of type III collagen. , 1987, The Journal of biological chemistry.
[82] M. Smith,et al. Molecular cloning and regional distribution of rat brain cyclophilin. , 1991, Brain research. Molecular brain research.
[83] C. Walsh,et al. Active site mutants of human cyclophilin A separate peptidyl‐prolyl isomerase activity from cyclosporin A binding and calcineurin inhibition , 1992, Protein science : a publication of the Protein Society.
[84] S. Yagi,et al. Yeast cyclophilin-related gene encodes a nonessential second peptidyl-prolyl cis-trans isomerase associated with the secretory pathway. , 1991, Transplantation proceedings.
[85] Solomon H. Snyder,et al. High brain densities of the immunophilin FKBP colocalized with calcineurin , 1992, Nature.
[86] N. Roehm,et al. Rapamycin and FK506 differentially inhibit mast cell cytokine production and cytokine-induced proliferation and act as reciprocal antagonists. , 1992, The Journal of pharmacology and experimental therapeutics.
[87] Argaet Vp,et al. Cyclophilin of Schistosoma japonicum. , 1992 .
[88] J. H. Collins. Sequence analysis of the ryanodine receptor: possible association with a 12K, FK506-binding immunophilin/protein kinase C inhibitor. , 1991, Biochemical and biophysical research communications.
[89] B. Sampson,et al. Neisseria meningitidis encodes an FK506-inhibitable rotamase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[90] J. Springer,et al. FK-506-binding protein: three-dimensional structure of the complex with the antagonist L-685,818. , 1994, The Journal of biological chemistry.
[91] C. Lee,et al. FK-506 binding protein from Tolypocladium inflatum: resistance of FKBP/FK-506 complex against proteolysis. , 1992, Biochemical and biophysical research communications.
[92] D. Speicher,et al. Isolation and amino acid sequence of cyclophilin. , 1986, The Journal of biological chemistry.
[93] S. Schreiber,et al. Effects of cyclosporin A and FK506 on Fc epsilon receptor type I-initiated increases in cytokine mRNA in mouse bone marrow-derived progenitor mast cells: resistance to FK506 is associated with a deficiency in FK506-binding protein FKBP12. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[94] E. Eikenberry,et al. Formation of the triple helix of type I procollagen in cellulo. A kinetic model based on cis-trans isomerization of peptide bonds. , 1981, European journal of biochemistry.
[95] H. Bächinger,et al. Thermal stability and folding of type IV procollagen and effect of peptidyl-prolyl cis-trans-isomerase on the folding of the triple helix. , 1989, The Journal of biological chemistry.
[96] F. Dumont,et al. The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin , 1992, The Journal of experimental medicine.
[97] Armin Widmer,et al. Peptide conformations. Part 31. The conformation of cyclosporin a in the crystal and in solution , 1985 .
[98] Michael Rosen,et al. Naturstoffe als Sonden zum Studium zellulärer Funktionen-Untersuchungen von Immunophilinen , 1992 .
[99] N. Takahashi,et al. Complementary DNA encoding the human T-cell FK506-binding protein, a peptidylprolyl cis-trans isomerase distinct from cyclophilin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[100] F. Schmid,et al. Enzymatic catalysis of prolyl isomerization in an unfolding protein. , 1992, Biochemistry.
[101] W. Neupert,et al. Sensitivity to cyclosporin A is mediated by cyclophilin in Neurospora crassa and Saccharomyces cerevisiae , 1989, Nature.
[102] M. V. Regenmortel,et al. MOLECULAR CHARACTERISTICS OF CYCLOPHILIN‐CYCLOSPORINE INTERACTION , 1988, Transplantation.
[103] D. Kern,et al. The cis/trans interconversion of the calcium regulating hormone calcitonin is catalyzed by cyclophilin , 1993, FEBS letters.
[104] S. Schreiber,et al. Molecular cloning of a membrane-associated human FK506- and rapamycin-binding protein, FKBP-13. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[105] R. Raines,et al. Solvent Effects on the Energetics of Prolyl Peptide Bond Isomerization. , 1992, Journal of the American Chemical Society.
[106] C. Lyttle,et al. Leukocyte chemotactic activity of FKBP and inhibition by FK506. , 1992, Biochemical and biophysical research communications.
[107] I. Weissman,et al. Cloning and characterization of cyclophilin C-associated protein: a candidate natural cellular ligand for cyclophilin C. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[108] D. Wetlaufer. Prolyl isomerization: How significant for in vivo protein folding? , 1985 .
[109] G. Wider,et al. Structure of human cyclophilin and its binding site for cyclosporin A determined by X-ray crystallography and NMR spectroscopy , 1991, Nature.
[110] T. Kuno,et al. Detection of the FK506-FKBP-calcineurin complex by a simple binding assay. , 1993, Biochemical and biophysical research communications.
[111] D. Livingston,et al. PPIase catalysis by human FK506-binding protein proceeds through a conformational twist mechanism. , 1992, The Journal of biological chemistry.
[112] B. Ryffel,et al. Distribution of the cyclosporine binding protein cyclophilin in human tissues. , 1991, Immunology.
[113] N. Morin,et al. Yeast FKBP-13 is a membrane-associated FK506-binding protein encoded by the nonessential gene FKB2. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[114] C. Mody,et al. A Legionella pneumophila gene encoding a species-specific surface protein potentiates initiation of intracellular infection , 1989, Infection and immunity.
[115] P. Caroni,et al. s-cyclophilin is retained intracellularly via a unique COOH-terminal sequence and colocalizes with the calcium storage protein calreticulin , 1992, The Journal of cell biology.
[116] P. S. Kim,et al. Specific intermediates in the folding reactions of small proteins and the mechanism of protein folding. , 1982, Annual review of biochemistry.
[117] E. Bamberg,et al. A unifying concept for ion translocation by retinal proteins , 1992, Journal of bioenergetics and biomembranes.
[118] B. Bierer,et al. Molecular cloning of a 25-kDa high affinity rapamycin binding protein, FKBP25. , 1992, The Journal of biological chemistry.
[119] S. Fields,et al. A novel genetic system to detect proteinprotein interactions , 1989, Nature.
[120] S. Schreiber,et al. Immunophilin ligands demonstrate common features of signal transduction leading to exocytosis or transcription. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[121] G. Crabtree,et al. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases , 1992, Cell.
[122] R. Stein,et al. Mechanistic studies of peptidyl prolyl cis-trans isomerase: evidence for catalysis by distortion. , 1990, Biochemistry.
[123] P. Klotman,et al. Cellular and molecular mechanisms of cyclosporin nephrotoxicity. , 1990, Journal of the American Society of Nephrology : JASN.
[124] F. Schmid,et al. Isolation and sequence of an FK506-binding protein from N. crassa which catalyses protein folding , 1990, Nature.
[125] T. Hayano,et al. Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin , 1989, Nature.
[126] A. Tomasselli,et al. The Hsp56 component of steroid receptor complexes binds to immobilized FK506 and shows homology to FKBP-12 and FKBP-13. , 1992, The Journal of biological chemistry.
[127] H. Husi,et al. Covalent binding of cyclosporine inhibits irreversibly T-lymphocyte activation. , 1992, Biochemical pharmacology.
[128] A. Dilella,et al. Exon organization of the human FKBP-12 gene: correlation with structural and functional protein domains. , 1991, Biochemistry.
[129] R F Standaert,et al. Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin. , 1993, Journal of molecular biology.
[130] J. Engel,et al. The zipper-like folding of collagen triple helices and the effects of mutations that disrupt the zipper. , 1991, Annual review of biophysics and biophysical chemistry.
[131] V. Hsu,et al. Peptidyl-prolyl cis-trans isomerase activity of cyclophilin studied by one-dimensional proton nuclear magnetic resonance spectroscopy , 1990 .
[132] S. Birkelund,et al. Chlamydia trachomatis Mip‐like protein , 1992, Molecular microbiology.
[133] M. Lightowlers,et al. Amino acid sequence homology between cyclophilin and a cDNA-cloned antigen of Echinococcus granulosus. , 1989, Molecular and biochemical parasitology.
[134] E. R. Sánchez,et al. Potentiation of glucocorticoid receptor-mediated gene expression by the immunophilin ligands FK506 and rapamycin. , 1993, The Journal of biological chemistry.
[135] D. Egan,et al. Isotope-edited NMR of cyclosporin A bound to cyclophilin: evidence for a trans 9,10 amide bond. , 1990, Science.
[136] Protein Folding and Protein Association , 1984 .
[137] N. Cianciotto,et al. DNA sequence of mip, a Legionella pneumophila gene associated with macrophage infectivity , 1989, Infection and immunity.
[138] A. Rao,et al. Nuclear factor of activated T cells contains Fos and Jun , 1992, Nature.
[139] J. Kunz,et al. Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression , 1993, Cell.
[140] S. Schreiber,et al. The conformation of cyclosporin a bound to cyclophilin is altered (once again) following binding to calcineurin: an analysis of receptor-ligand-receptor interactions , 1992 .
[141] H. Husi,et al. Identification of several cyclosporine binding proteins in lymphoid and non-lymphoid cells in vivo. , 1992, Biochimica et biophysica acta.
[142] R. Morris,et al. Rapamycin: FK506's fraternal twin or distant cousin? , 1991, Immunology today.
[143] T. Starzl,et al. Hepatotrophic properties in dogs of human FKBP, the binding protein for FK506 and rapamycin. , 1991, Transplantation.
[144] F. Schmid,et al. The mechanism of protein folding. Implications of in vitro refolding models for de novo protein folding and translocation in the cell. , 1990, Biochemistry.
[145] A. Pérez-Castillo,et al. Thyroid hormone up-regulates NGFI-A gene expression in rat brain during development. , 1992, The Journal of biological chemistry.
[146] B. Ryffel,et al. Cyclosporin A: action and side-effects. , 1989, Toxicology letters.
[147] K. Ziegler,et al. Identification of cyclosporin binding sites in rat liver plasma membranes, isolated hepatocytes, and hepatoma cells by photoaffinity labeling using [3H]cyclosporin-diaziridine. , 1986, Biochimica et biophysica acta.
[148] N. Iwai,et al. Molecular cloning of a complementary DNA to rat cyclophilin-like protein mRNA. , 1990, Kidney international.
[149] B. Stollar,et al. Involvement of dipeptidyl peptidase IV in an in vivo immune response , 1992, Clinical and experimental immunology.
[150] N. Takahashi,et al. Catalysis of protein folding by cyclophilins from different species. , 1991, The Journal of biological chemistry.
[151] A. Cerami,et al. Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[152] H. C. Wu,et al. Nucleotide sequence of the Pseudomonas fluorescens signal peptidase II gene (lsp) and flanking genes , 1990, Journal of bacteriology.
[153] M. Fitzgibbon,et al. Solution structure of the major binding protein for the immunosuppressant FK506 , 1991, Nature.
[154] M. Mclaughlin,et al. The cyclophilin multigene family of peptidyl-prolyl isomerases. Characterization of three separate human isoforms. , 1991, The Journal of biological chemistry.
[155] A. Pahl,et al. Streptomycetes possess peptidyl‐prolyl cis‐trans isomerases that strongly resemble cyclophilins from eukaryotic organisms , 1992, Molecular microbiology.
[156] Maximilian Tropschug,et al. Nucleotide sequence of the gene coding for cyclophilin/peptidyl-prolyl cis-trans isomerase of Neurospora crassa , 1990, Nucleic Acids Res..
[157] Crystallographic analysis of the interaction between cyclosporin A and the Fab fragment of a monoclonal antibody , 1993, Proteins.
[158] H P Kocher,et al. Yeast cyclophilin: isolation and characterization of the protein, cDNA and gene. , 1989, Gene.
[159] W F van Gunsteren,et al. On the dependence of molecular conformation on the type of solvent environment: A molecular dynamics study of cyclosporin A , 1990, Biopolymers.
[160] J. Hacker,et al. Mip protein of Legionella pneumophila exhibits peptidyl‐prolyl‐cis/trans isomerase (PPIase) activity , 1992, Molecular microbiology.
[161] J. Brandts,et al. Isomer-specific proteolysis of model substrates: influence that the location of the proline residue exerts on cis/trans specificity. , 1985, Biochemistry.
[162] D. Bergsma,et al. Rapamycin sensitivity in Saccharomyces cerevisiae is mediated by a peptidyl-prolyl cis-trans isomerase related to human FK506-binding protein. , 1991, Molecular and cellular biology.
[163] P. Casey,et al. Biochemistry of protein prenylation. , 1992, Journal of lipid research.
[164] R. Handschumacher,et al. Isolation and characterization of a 40-kDa cyclophilin-related protein. , 1992, The Journal of biological chemistry.
[165] Jun O. Liu,et al. Cloning, expression, and purification of human cyclophilin in Escherichia coli and assessment of the catalytic role of cysteines by site-directed mutagenesis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[166] Y. Thériault,et al. Solution structure of the cyclosporin A/cyclophilin complex by NMR , 1993, Nature.
[167] D. Seebach,et al. Novel backbone conformation of cyclosporin A: the complex with lithium chloride , 1992 .
[168] R. Moritz,et al. The cyclophilin component of the unactivated estrogen receptor contains a tetratricopeptide repeat domain and shares identity with p59 (FKBP59). , 1993, The Journal of biological chemistry.
[169] S. Soldin,et al. Cyclosporin G and metabolite binding to cyclophilin and a 50-kDa binding protein related to in vitro immunosuppression. , 1993, Clinical chemistry.
[170] R. Contreras,et al. The nucleotide sequence of a third cyclophilin‐homologous gene from Saccharomyces cerevisiae , 1991, Yeast.
[171] M. Walkinshaw,et al. X-ray structure of a decameric cyclophilin-cyclosporin crystal complex , 1993, Nature.
[172] Determination of kinetic constants for peptidyl prolyl cis-trans isomerases by an improved spectrophotometric assay. , 1991 .
[173] D. G. Davis,et al. Bradykinin and its Gly6 analogue are substrates of cyclophilin: a fluorine-19 magnetization transfer study. , 1990, Biochemistry.
[174] J. Brandts,et al. Catalysis of proline isomerization during protein-folding reactions. , 1988, Biochimica et biophysica acta.
[175] R. Stein,et al. Substrate specificities of the peptidyl prolyl cis-trans isomerase activities of cyclophilin and FK-506 binding protein: evidence for the existence of a family of distinct enzymes. , 1990, Biochemistry.
[176] Richard S. Rosenstein,et al. Intramolecular catalysis of a proline isomerization reaction in the folding of dihydrofolate reductase. , 1992, Biochemistry.
[177] P. Colombani,et al. Cyclosporin A binding to calmodulin: a possible site of action on T lymphocytes. , 1985, Science.
[178] J. T. Gerig. The effect of adjacent charges on the kinetics of rotation of the peptide bond , 1971, Biopolymers.
[179] J. Kofron,et al. Continuous fluorimetric direct (uncoupled) assay for peptidyl prolyl cis-trans isomerases , 1992 .
[180] B. Haendler,et al. A novel secreted cyclophilin-like protein (SCYLP). , 1991, The Journal of biological chemistry.
[181] M. Lerman,et al. Localization of a novel natural killer triggering receptor locus to human chromosome 3p23-p21 and mouse chromosome 9. , 1993, Genomics.
[182] Stephen W. Fesik,et al. A model of the cyclophilin/cyclosporin A (CSA) complex from NMR and X-ray data suggests that CSA binds as a transition-state analog , 1992 .
[183] N. Sigal,et al. Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A? , 1991, The Journal of experimental medicine.
[184] P. Caroni,et al. S-cyclophilin. New member of the cyclophilin family associated with the secretory pathway. , 1991, The Journal of biological chemistry.
[185] C. Walsh,et al. Human cyclophilin B: a second cyclophilin gene encodes a peptidyl-prolyl isomerase with a signal sequence. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[186] Jean M. Severin,et al. High-level expression of recombinant human FK-binding protein from a fusion precursor , 1992, Journal of protein chemistry.
[187] K. Kawahara,et al. INHIBITION OF THE MULTIDRUG EFFLUX PUMP IN ISOLATED HEPATOCYTE COUPLETS BY IMMUNOSUPPRESSANTS FK506 AND CYCLOSPORINE , 1993, Transplantation.
[188] J. Avruch,et al. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. , 1992, Science.
[189] B. Erlanger. Why cyclosporin is an effective drug. , 1993, Immunology today.
[190] D. Tweardy,et al. FK 506, rapamycin, and cyclosporine: effects on IL-4 and IL-10 mRNA levels in a T-helper 2 cell line. , 1991, Transplantation proceedings.
[191] M. Kobayashi,et al. Production of monoclonal antibody against recombinant human FKBP-12 and subcellular localization of FKBP-12 in human mononuclear and polymorphonuclear cells. , 1993, Transplantation proceedings.
[192] S. Schreiber,et al. Activation of an inactive immunophilin by mutagenesis , 1993 .
[193] J. Liu,et al. Peptidyl-prolyl cis-trans-isomerase from Escherichia coli: a periplasmic homolog of cyclophilin that is not inhibited by cyclosporin A. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[194] A. Tartar,et al. Slow isomerization of some proline-containing peptides inducing peak splitting during reversed-phase high-performance liquid chromatography , 1989 .
[195] S. Ōmura,et al. New strategy for discovery of enzyme inhibitors: screening with intact mammalian cells or intact microorganisms having special functions. , 1990, The Journal of antibiotics.
[196] F. Schmid,et al. Peptidyl-prolyl cis-trans isomerase improves the efficiency of protein disulfide isomerase as a catalyst of protein folding. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[197] S. Rouby,et al. Comparison of the properties of the CsA analogs monoacetyl CyC (o‐acetyl‐threonine2 cyclosporin) and methyl‐alanyl CsA (N‐methyl‐L‐alanyl6 cyclosporin); monoacetyl cyclosporin is immunosuppressive without binding to cyclophilin , 1992, Clinical and experimental immunology.
[198] R. Jaenicke,et al. Folding and association of proteins. , 1982, Biophysics of structure and mechanism.
[199] R. Williams,et al. Design and synthesis of novel FKBP inhibitors. , 1992, Journal of medicinal chemistry.
[200] C. Zuker,et al. The ninaA gene required for visual transduction in Drosophila encodes a homologue of cyclosporin A-binding protein , 1989, Nature.
[201] M Karplus,et al. Solution structure of FKBP, a rotamase enzyme and receptor for FK506 and rapamycin , 1991, Science.
[202] M. Crompton,et al. The presence of two classes of high-affinity cyclosporin A binding sites in mitochondria. Evidence that the minor component is involved in the opening of an inner-membrane Ca(2+)-dependent pore. , 1990, European journal of biochemistry.
[203] B. Huber,et al. Inhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T-cell function. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[204] Stuart L. Schreiber,et al. Natural Products as Probes of Cellular Function: Studies of Immunophilins , 1992 .
[205] F. Schmid,et al. Catalysis of protein folding by prolyl isomerase , 1987, Nature.
[206] S. Schreiber,et al. cDNA cloning of a human 25 kDa FK506 and rapamycin binding protein. , 1992, Biochemical and biophysical research communications.
[207] A. Marks,et al. The calcium release channel of sarcoplasmic reticulum is modulated by FK-506-binding protein. Dissociation and reconstitution of FKBP-12 to the calcium release channel of skeletal muscle sarcoplasmic reticulum. , 1993, The Journal of biological chemistry.
[208] G. Fischer,et al. The conformation around the peptide bond between the P1- and P2-positions is important for catalytic activity of some proline-specific proteases. , 1983, Biochimica et biophysica acta.
[209] A. Berger,et al. On the size of the active site in proteases. I. Papain. , 1967, Biochemical and biophysical research communications.
[210] C. Richter,et al. Sensitivity of mitochondrial peptidyl-prolyl cis-trans isomerase, pyridine nucleotide hydrolysis and Ca2+ release to cyclosporine A and related compounds. , 1993, Biochemical pharmacology.
[211] Derk J. Bergsma,et al. A Chinese hamster ovary cyclophilin cDNA sequence , 1990, Nucleic Acids Res..
[212] K Wüthrich,et al. The NMR structure of cyclosporin A bound to cyclophilin in aqueous solution. , 1991, Biochemistry.
[213] R F Standaert,et al. Atomic structure of FKBP-FK506, an immunophilin-immunosuppressant complex , 1991, Science.
[214] L. Philipson,et al. The gene for cyclophilin (peptidyl-prolyl cis-trans isomerase) from Schizosaccharomyces pombe. , 1990, Nucleic acids research.
[215] F. Dumont,et al. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. , 1989, Journal of immunology.
[216] J. Roder,et al. A cyclophilin-related protein involved in the function of natural killer cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[217] R. Jaenicke. Proteinfaltung und Proteinassoziation , 1984 .
[218] R. Russell,et al. Correlation of cyclosporine and metabolite binding to cyclophilin and a 50 kDa binding protein with in vitro immunosuppression: a preliminary report. , 1991, Clinical biochemistry.
[219] M. Marahiel,et al. Peptidyl‐prolyl cis‐trans isomerase from Bacillus subtilis A prokaryotic enzyme that is highly sensitive to cyclosporin A , 1992, FEBS letters.
[220] S. Schreiber,et al. Controlling signal transduction with synthetic ligands. , 1993, Science.
[221] J. Kofron,et al. Fluorescence displacement method for the determination of receptor-ligand binding constants. , 1992, Analytical biochemistry.
[222] S. Forsén,et al. Peptidyl‐prolyl cis‐trans isomerase activity as studied by dynamic proton NMR spectroscopy , 1991, FEBS letters.
[223] S. Schreiber,et al. A rapamycin-selective 25-kDa immunophilin. , 1992, Biochemistry.
[224] M. Wainberg,et al. The effect of cyclosporine A on infection of susceptible cells by human immunodeficiency virus type 1. , 1988, Blood.
[225] L A Herzenberg,et al. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[226] A. Petros,et al. Three-dimensional structure of the FK506 binding protein/ascomycin complex in solution by heteronuclear three- and four-dimensional NMR. , 1993, Biochemistry.
[227] R. Stein,et al. Mechanistic studies of enzymic and nonenzymic prolyl cis-trans isomerization , 1992 .
[228] J. McPherson,et al. Somatic cell mapping of the human cyclophilin B gene (PPIB) to chromosome 15. , 1992, Cytogenetics and cell genetics.
[229] J. Kofron,et al. A continuous spectrophotometric direct assay for peptidyl prolyl cis-trans isomerases. , 1993, Biochemical and biophysical research communications.
[230] B. Jonsson,et al. Cis‐trans isomerization is rate‐determining in the reactivation of denatured human carbonic anhydrase II as evidenced by proline isomerase , 1992, FEBS letters.
[231] B. Haendler,et al. Complementary DNA for human T‐cell cyclophilin. , 1987, The EMBO journal.
[232] P R Connelly,et al. Heat capacity changes and hydrophobic interactions in the binding of FK506 and rapamycin to the FK506 binding protein. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[233] M. Murcko,et al. Charged surface residues of FKBP12 participate in formation of the FKBP12-FK506-calcineurin complex. , 1992, The Journal of biological chemistry.
[234] J. Lippke,et al. Expression and characterization of human FKBP52, an immunophilin that associates with the 90-kDa heat shock protein and is a component of steroid receptor complexes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[235] J. Sambrook,et al. Protein folding in the cell , 1992, Nature.
[236] B. Haendler,et al. Characterization of the human cyclophilin gene and of related processed pseudogenes. , 1990, European journal of biochemistry.
[237] J. Sambrook,et al. Proline isomerases function during heat shock. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[238] B. Erlanger,et al. Evidence for a functional receptor for cyclosporin A on the surface of lymphocytes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[239] S. Schreiber,et al. Substrate specificity for the human rotamase FKBP: a view of FK506 and rapamycin as leucine-(twisted amide)-proline mimics , 1990 .
[240] E. Baulieu,et al. Rabbit FKBP59-heat shock protein binding immunophillin (HBI) is a calmodulin binding protein. , 1992, Biochemical and biophysical research communications.
[241] J. Friedman,et al. Two cytoplasmic candidates for immunophilin action are revealed by affinity for a new cyclophilin: One in the presence and one in the absence of CsA , 1991, Cell.
[242] S. Schreiber,et al. Association of a 59-kilodalton immunophilin with the glucocorticoid receptor complex. , 1992, Science.
[243] C. Zuker,et al. The cyclophilin homolog ninaA is a tissue-specific integral membrane protein required for the proper synthesis of a subset of Drosophila rhodopsins , 1991, Cell.
[244] N. Sigal,et al. Isolation of a human cDNA encoding a 25 kDa FK-506 and rapamycin binding protein. , 1992, Biochemical and biophysical research communications.
[245] N. Sigal,et al. The cytosolic-binding protein for the immunosuppressant FK-506 is both a ubiquitous and highly conserved peptidyl-prolyl cis-trans isomerase. , 1990, The Journal of biological chemistry.
[246] D. Donald,et al. C10 N-Acyl modified FK-506: A possible hybrid analogue of the transition state of peptidyl-prolyl cis-trans isomerization. , 1991 .
[247] J. Hacker,et al. Immunophilins: structure—function relationship and possible role in microbial pathogenicity , 1993, Molecular microbiology.
[248] F. Schmid,et al. Prolyl isomerases: role in protein folding. , 1993, Advances in protein chemistry.
[249] P. Frendo,et al. Effects of abiotic stresses on cyclophilin gene expression in maize and bean and sequence analysis of bean cyclophilin cDNA , 1992 .
[250] B. Jonsson,et al. Isomerase and chaperone activity of prolyl isomerase in the folding of carbonic anhydrase. , 1992, Science.
[251] V. Berlin,et al. The FKB2 gene of Saccharomyces cerevisiae, encoding the immunosuppressant-binding protein FKBP-13, is regulated in response to accumulation of unfolded proteins in the endoplasmic reticulum. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[252] H. Erdjument-Bromage,et al. FK506 binding protein associated with the calcium release channel (ryanodine receptor). , 1992, The Journal of biological chemistry.
[253] S. Schreiber,et al. A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase , 1989, Nature.
[254] S. Schreiber,et al. Inhibition of FKBP rotamase activity by immunosuppressant FK506: twisted amide surrogate. , 1990, Science.
[255] J J Burbaum,et al. Improved calcineurin inhibition by yeast FKBP12-drug complexes. Crystallographic and functional analysis. , 1993, The Journal of biological chemistry.
[256] S. Schreiber,et al. Chromosomal band assignments of the genes encoding human FKBP12 and FKBP13. , 1992, Biochemical and biophysical research communications.
[257] H. Ke,et al. Crystal structure of cyclophilin A complexed with substrate Ala-Pro suggests a solvent-assisted mechanism of cis-trans isomerization. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[258] J. Macdonald,et al. Structural and functional characterization of Escherichia coli peptidyl-prolyl cis-trans isomerases. , 1992, European journal of biochemistry.
[259] S. Forsén,et al. Peptidyl‐prolyl cis‐trans isomerase does not affect the Pro‐43 cis‐trans isomerization rate in folded calbindin D9k , 1990, FEBS letters.
[260] M. Nilsen-Hamilton,et al. Basic fibroblast growth factor induces 3T3 fibroblasts to synthesize and secrete a cyclophilin-like protein and β2-microglobulin , 1991 .
[261] F. Hartl,et al. Cyclosporin A-binding protein (cyclophilin) of Neurospora crassa. One gene codes for both the cytosolic and mitochondrial forms. , 1988, The Journal of biological chemistry.
[262] A. Chakrabarty,et al. Nucleotide sequence of a regulatory region controlling alginate synthesis in Pseudomonas aeruginosa: characterization of the algR2 gene. , 1989, Gene.
[263] J. Brandts,et al. Evidence showing that a proline-specific endopeptidase has an absolute requirement for a trans peptide bond immediately preceding the active bond. , 1983, Biochemistry.
[264] S. Soldin,et al. Purification and characterization of cyclosporine and FK-506 binding proteins from a human T-helper cell line. , 1991, Clinical biochemistry.
[265] Structural similarity of the binding sites of cyclophilin A-cyclosporin A and FKBP-FK506 systems. , 1993, Biochemical and biophysical research communications.
[266] C. Zuker,et al. Cyclophilins: a new family of proteins involved in intracellular folding. , 1992, Trends in cell biology.
[267] T. Aoyagi,et al. Pepstatin, a new pepsin inhibitor produced by Actinomycetes. , 1970, The Journal of antibiotics.
[268] N. Sigal,et al. Cyclosporin A, FK-506, and Rapamycin: Pharmacologic Probes of Lymphocyte Signal Transduction , 1992 .
[269] Jeremy Luban,et al. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B , 1993, Cell.
[270] J. Pearce,et al. Chlamydia trachomatis Mip‐like protein has peptidylprolyl cis/trans isomerase activity that is inhibited by FK506 and rapamycin and is implicated in initiation of chlamydial infection , 1993, Molecular microbiology.
[271] C. Zuker,et al. The cyclophilin homolog ninaA is required in the secretory pathway , 1991, Cell.
[272] A. Plückthun,et al. The Effect of Folding Catalysts on the In Vivo Folding Process of Different Antibody Fragments Expressed in Escherichia coli , 1993, Bio/Technology.
[273] H. Halvorson,et al. Consideration of the Possibility that the slow step in protein denaturation reactions is due to cis-trans isomerism of proline residues. , 1975, Biochemistry.
[274] A. Ménez,et al. On the localization of FKBP25 in T‐lymphocytes , 1993, FEBS letters.
[275] M. Murcko,et al. cDNA encoding murine FK506-binding protein (FKBP): nucleotide and deduced amino acid sequence. , 1991, Gene.
[276] D. Seebach,et al. Complexation and medium effects on the conformation of cyclosporin A studied by NMR spectroscopy and molecular dynamics calculations. , 1990, Biochemical pharmacology.
[277] W. Kenney,et al. Multiple peak formation from reversed-phase liquid chromatography of recombinant human platelet-derived growth factor. , 1992, Journal of chromatography.
[278] A. Halestrap,et al. Further evidence that cyclosporin A protects mitochondria from calcium overload by inhibiting a matrix peptidyl-prolyl cis-trans isomerase. Implications for the immunosuppressive and toxic effects of cyclosporin. , 1991, The Biochemical journal.
[279] J. Goodman,et al. Specific cross-linking of the proline isomerase cyclophilin to a non-proline-containing peptide. , 1993, Molecular biology of the cell.
[280] M. Walkinshaw,et al. The X‐ray structure of a tetrapeptide bound to the active site of human cyclophilin A , 1992, FEBS letters.
[281] C. Gasser,et al. Structure and expression of cytosolic cyclophilin/peptidyl-prolyl cis-trans isomerase of higher plants and production of active tomato cyclophilin in Escherichia coli. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[282] W. Marks,et al. The immunochemical distribution of cyclophilin in normal mammalian tissues. , 1991, Transplantation.
[283] D. Rich,et al. Immunosuppressive activity of [MeBm2t]1-, D-diaminobutyryl-8-, and D-diaminopropyl-8-cyclosporin analogues correlates with inhibition of calcineurin phosphatase activity. , 1993, Journal of immunology.
[284] Stephen W. Fesik,et al. Lithium chloride perturbation of cis-trans peptide bond equilibria: effect on conformational equilibria in cyclosporin A and on time-dependent inhibition of cyclophilin , 1992 .
[285] F. Dumont,et al. A study of the correlation between cyclophilin binding and in vitro immunosuppressive activity of cyclosporine A and analogues. , 1988, Transplantation proceedings.
[286] A. Burny,et al. An immunophilin that binds M(r) 90,000 heat shock protein: main structural features of a mammalian p59 protein. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[287] W. Marks,et al. THE EFFECT OF CYCLOSPORINE ADMINISTRATION ON THE CELLULAR DISTRIBUTION AND CONTENT OF CYCLOPHILIN 1 , 1992, Transplantation.
[288] W. Franke,et al. Sequence analysis of cytoplasmic mRNA-binding proteins of Xenopus oocytes identifies a family of RNA-binding proteins. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[289] Victor L. Hsu,et al. Solution structure of cyclosporin A and a nonimmunosuppressive analog bound to fully deuterated cyclophilin. , 1992, Biochemistry.
[290] S. Schreiber,et al. Immunosuppressants implicate protein phosphatase regulation of K+ channels in guard cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[291] F. Schmid. Fast-folding and slow-folding forms of unfolded proteins. , 1986, Methods in enzymology.